Kirin Biomaterials is a pharmaceutical company based in Japan. Its disclosed U.S. lobbying activity focuses on supporting the manufacture of bulk pharmaceuticals, a manufacturing-related issue. Filings show one disclosure with no reported spending and the use of The Conafay Group, LLC as its lobby firm.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRYAN SHUY
The latest disclosures for this client.
THE CONAFAY GROUP, LLC
Q3THE CONAFAY GROUP, LLC
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE CONAFAY GROUP, LLC
EVIE SMITH
THE CONAFAY GROUP, LLC
JULIE P. PAWELCZYK
THE CONAFAY GROUP, LLC
BRIAN TSE
THE CONAFAY GROUP, LLC
mr BRIAN NOEL TSE
THE CONAFAY GROUP, LLC
THE CONAFAY GROUP, LLC
RR